These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PSA AND Prognosis
20 results:

  • 1. The survival of the prostate cancer patients with secondary colorectal cancer: a study based on a SEER database from southern China.
    Lin L; Huang L; Li YL; Shan H
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):1128-1133. PubMed ID: 36808373
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Postoperative complications are associated with poor survival outcome after curative resection for colorectal cancer: A propensity-score analysis.
    Miyamoto Y; Hiyoshi Y; Tokunaga R; Akiyama T; Daitoku N; Sakamoto Y; Yoshida N; Baba H
    J Surg Oncol; 2020 Aug; 122(2):344-349. PubMed ID: 32346880
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Validation of a subclassification for high-risk prostate cancer in a prospective cohort.
    Butler SS; Dee EC; Lamba N; Sha ST; Mahal BA; Whitbeck A; Makkar R; Wangoe J; Mouw KW; Nguyen PL; Muralidhar V
    Cancer; 2020 May; 126(10):2132-2138. PubMed ID: 32073662
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous Prostate cancer with Intact MMR: Diagnosis and Analysis of the Family Pedigree.
    Liu W; Zhang D; Tan SA; Liu X; Lai J
    Anticancer Res; 2018 Aug; 38(8):4847-4852. PubMed ID: 30061258
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identifying cancer origin using circulating tumor cells.
    Lu SH; Tsai WS; Chang YH; Chou TY; Pang ST; Lin PH; Tsai CM; Chang YC
    Cancer Biol Ther; 2016 Apr; 17(4):430-8. PubMed ID: 26828696
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Altered Activity and Expression of Cytosolic Peptidases in colorectal cancer.
    Perez I; Blanco L; Sanz B; Errarte P; Ariz U; Beitia M; Fernández A; Loizate A; Candenas ML; Pinto FM; Gil J; López JI; Larrinaga G
    Int J Med Sci; 2015; 12(6):458-67. PubMed ID: 26078706
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. If you have an active vagus nerve, cancer stage may no longer be important.
    Gidron Y; De Couck M; De Greve J
    J Biol Regul Homeost Agents; 2014; 28(2):195-201. PubMed ID: 25001652
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
    Scorilas A; Mavridis K
    Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.
    Harouaka R; Kang Z; Zheng SY; Cao L
    Pharmacol Ther; 2014 Feb; 141(2):209-21. PubMed ID: 24134902
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Prostate cancer in Luxembourg from 1982 to 2006. Incidence and mortality. Survival of a hospital cohort].
    Lamy S; Wilmart JF; Hein T; Scheiden R; Capesius C
    Bull Soc Sci Med Grand Duche Luxemb; 2013; (1):6-19. PubMed ID: 23808106
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
    Alexopoulou DK; Papadopoulos IN; Scorilas A
    Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
    Jonsson L; Gaber A; Ulmert D; Uhlén M; Bjartell A; Jirström K
    Diagn Pathol; 2011 Sep; 6():91. PubMed ID: 21955582
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Penile metastasis from adenocarcinoma of the prostate in a patient with colorectal carcinoma.
    Yildiz B; Fidan E; Yildiz K; Aydin F
    Acta Dermatovenerol Croat; 2011; 19(1):36-8. PubMed ID: 21489365
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effect of human colorectal carcinogenesis on the neural cell adhesion molecule expression and polysialylation.
    Fernández-Briera A; García-Parceiro I; Cuevas E; Gil-Martín E
    Oncology; 2010; 78(3-4):196-204. PubMed ID: 20414008
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
    Avgeris M; Mavridis K; Scorilas A
    Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
    Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
    Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: the role of morphology and immunohistochemistry.
    Owens CL; Epstein JI; Netto GJ
    Arch Pathol Lab Med; 2007 Apr; 131(4):599-603. PubMed ID: 17425391
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Ganglion curage in prostate cancer].
    Schumacher M; Burkhard FC; Studer UE
    Ann Urol (Paris); 2005 Oct; 39(5):197-202. PubMed ID: 16370170
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
    Canil CM; Tannock IF
    Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.